Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker COO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Lawrence Erik Kurzius Director | COO The Cooper Companies, Inc. | Buy | 10,000 | $54.93 | $549.3K Buy | Form 4 ↗ |
| Sep 14, 2026 | Walter M. Rosebrough Jr. Director | COO The Cooper Companies, Inc. | Buy | 3,000 | $54.29 | $162.9K Buy | Form 4 ↗ |
| Sep 14, 2026 | Lawrence Erik Kurzius Director | COO The Cooper Companies, Inc. | Buy | 10,000 | $53.92 | $539.2K Buy | Form 4 ↗ |
| Sep 11, 2026 | Paul A. Keel Director | COO The Cooper Companies, Inc. | Buy | 4,701 | $53.18 | $250.0K Buy | Form 4 ↗ |
| Sep 11, 2026 | Walter M. Rosebrough Jr. Director | COO The Cooper Companies, Inc. | Buy | 7,000 | $54.11 | $378.8K Buy | Form 4 ↗ |
| Dec 22, 2025 | Cynthia L. Lucchese Director | COO The Cooper Companies, Inc. | Buy | 1,784 | $84.06 | $150.0K Buy | Form 4 ↗ |
| Dec 18, 2025 | Maria Rivas Director | COO The Cooper Companies, Inc. | Buy | 1,000 | $82.13 | $82.1K Buy | Form 4 ↗ |
| Dec 17, 2025 | Lawrence Erik Kurzius Director | COO The Cooper Companies, Inc. | Buy | 2,000 | $82.50 | $165.0K Buy | Form 4 ↗ |
| Dec 16, 2025 | Holly R. Sheffield President, CSI | COO The Cooper Companies, Inc. | Buy | 1,230 | $80.75 | $99.3K Buy | Form 4 ↗ |
| Dec 16, 2025 | Albert G. White III President & CEO, Director | COO The Cooper Companies, Inc. | Buy | 10,000 | $80.80 | $808.0K Buy | Form 4 ↗ |
| Sep 29, 2025 | Lawrence Erik Kurzius Director | COO The Cooper Companies, Inc. | Buy | 2,000 | $68.39 | $136.8K Buy | Form 4 ↗ |
| Sep 5, 2025 | Albert G. White III President & CEO, Director | COO The Cooper Companies, Inc. | Buy | 10,000 | $68.39 | $683.9K Buy | Form 4 ↗ |
| Sep 5, 2025 | Gerard H. Warner III President, CooperVision, Inc. | COO The Cooper Companies, Inc. | Buy | 1,450 | $69.23 | $100.4K Buy | Form 4 ↗ |
| Sep 2, 2025 | Daniel G. McBride EVP & Chief Operating Officer | COO The Cooper Companies, Inc. | Buy | 3,000 | $65.04 | $195.1K Buy | Form 4 ↗ |
| Sep 2, 2025 | Brian G. Andrews EVP, CFO & Treasurer | COO The Cooper Companies, Inc. | Buy | 1,525 | $65.68 | $100.2K Buy | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances